Viewing Study NCT00238368


Ignite Creation Date: 2025-12-24 @ 5:32 PM
Ignite Modification Date: 2026-02-01 @ 2:46 PM
Study NCT ID: NCT00238368
Status: COMPLETED
Last Update Posted: 2017-11-06
First Post: 2005-10-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: J0348 CDR0000445618
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View